<code id='529CC780ED'></code><style id='529CC780ED'></style>
    • <acronym id='529CC780ED'></acronym>
      <center id='529CC780ED'><center id='529CC780ED'><tfoot id='529CC780ED'></tfoot></center><abbr id='529CC780ED'><dir id='529CC780ED'><tfoot id='529CC780ED'></tfoot><noframes id='529CC780ED'>

    • <optgroup id='529CC780ED'><strike id='529CC780ED'><sup id='529CC780ED'></sup></strike><code id='529CC780ED'></code></optgroup>
        1. <b id='529CC780ED'><label id='529CC780ED'><select id='529CC780ED'><dt id='529CC780ED'><span id='529CC780ED'></span></dt></select></label></b><u id='529CC780ED'></u>
          <i id='529CC780ED'><strike id='529CC780ED'><tt id='529CC780ED'><pre id='529CC780ED'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:81826
          The future looks even brighter for the blockbuster Enhertu, showcased here at ASCO. ADAM FEUERSTEIN/STAT

          CHICAGO — The cancer drug Enhertu stalled the growth of tumors by more than a year, significantly longer than standard chemotherapy did in women with the most common form of metastatic breast cancer — a clinical trial result that once again promises to rewrite the rules for the treatment of the disease.

          The makers of Enhertu, Daiichi Sankyo and AstraZeneca, said the new data, if cleared by regulators, could shift the way physicians treat hormone receptor-positive, metastatic breast cancer, and create a new standard of care in which patients with breast tumors that express even the faintest amount of HER2 protein can benefit.

          advertisement

          “It’s not an overestimation to say that trastuzumab deruxtecan is the most potent drug ever developed for breast cancer,” said Paolo Tarantino, a medical oncologist at the Dana-Farber Cancer Institute, using the scientific name for Enhertu. “It does come with side effects that we’re learning to manage, but with that said, I’ve never seen data like what’s being reported here.”

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          'Vaccine
          'Vaccine

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesLEXINGTON,Mass.—NewobesitydrugslikeWegovyandZepboundarecurr

          read more
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more

          VC firm RA Capital starts a new synthetic biology incubator

          AdobeVenturecapitalfirmRACapitalisstartinganewincubator,settingthestageforthefirmtocreatenewstartups